相似文献
1
Carbenicillin administration in patients with severe renal failure.严重肾衰竭患者的羧苄青霉素给药
Br Med J. 1968 Feb 24;1(5590):486-7. doi: 10.1136/bmj.1.5590.486.
2
Carbenicillin therapy in renal failure.肾衰竭中的羧苄青霉素治疗。
Med J Aust. 1969 Oct 4;2(14):681-4. doi: 10.5694/j.1326-5377.1969.tb107344.x.
3
Colistin sulphomethate sodium administration in the presence of severe renal failure and during haemodialysis and peritoneal dialysis.在严重肾衰竭患者以及血液透析和腹膜透析期间给予硫酸多黏菌素B甲磺酸钠。
Br Med J. 1968 Feb 24;1(5590):484-5. doi: 10.1136/bmj.1.5590.484.
4
Administration of ticarcillin to patients with severe renal failure.替卡西林用于严重肾衰竭患者的给药。
Chemotherapy. 1974;20(6):339-41. doi: 10.1159/000221824.
5
Diuretic effect and pharmacokinetic data observed at different stages of chronic renal failure with 240 mg of muzolimine.
Z Kardiol. 1985;74 Suppl 2:88-91.
6
Doxycycline (Vibramycin) in chronic renal failure.慢性肾衰竭中的多西环素（强力霉素）。
Nephron. 1973;11(5):318-24. doi: 10.1159/000180239.
7
8
Mechanisms for inefficient peritoneal dialysis in acute renal failure associated with heat stress and exercise.热应激和运动相关急性肾衰竭中腹膜透析效率低下的机制。
Ann Intern Med. 1969 Aug;71(2):317-36. doi: 10.7326/0003-4819-71-2-317.
9
[Continuous ambulatory peritoneal dialysis. An alternative to hemodialysis].
Schweiz Rundsch Med Prax. 1984 Dec 18;73(51-52):1569-75.
10
Doxycycline: studies in normal subjects and patients with renal failure.强力霉素：在正常受试者和肾衰竭患者中的研究。
N Z Med J. 1972 Jun;75(481):355-8.
引用本文的文献
1
Piperacillin pharmacokinetics in subjects with chronic renal failure.哌拉西林在慢性肾衰竭患者中的药代动力学。
Antimicrob Agents Chemother. 1981 Mar;19(3):450-3. doi: 10.1128/AAC.19.3.450.
2
Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.肾功能受损、血液透析及腹膜透析对美洛西林药代动力学的影响。
Antimicrob Agents Chemother. 1980 Jul;18(1):81-7. doi: 10.1128/AAC.18.1.81.
3
Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.哌拉西林。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1984 Nov;28(5):375-425. doi: 10.2165/00003495-198428050-00002.
4
Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.接受血液透析患者的药物治疗。临床药代动力学考量
Clin Pharmacokinet. 1984 Jan-Feb;9(1):42-66. doi: 10.2165/00003088-198409010-00003.
5
Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.药物动力学特性的差异：对肾衰竭患者选用特定药物的意义，特别强调抗生素和β-肾上腺素能受体阻滞剂。
Clin Pharmacokinet. 1980 Sep-Oct;5(5):441-64. doi: 10.2165/00003088-198005050-00003.
6
Antibacterial agents in renal failure.
Br Med J. 1971 Mar 20;1(5750):621-2.
7
The pharmacokinetics of an oral form of carbenicillin in patients with renal failure.口服羧苄青霉素在肾衰竭患者中的药代动力学。
Postgrad Med J. 1972 Jul;48(561):422-6. doi: 10.1136/pgmj.48.561.422.
8
Hemodialysis at home.家庭血液透析
Can Med Assoc J. 1968 Oct 26;99(16):779-85.
9
Administration of ticarcillin, a new antipseudomonal antibiotic, in patients undergoing dialysis.在接受透析的患者中使用替卡西林（一种新型抗假单胞菌抗生素）。
Antimicrob Agents Chemother. 1974 Feb;5(2):119-20. doi: 10.1128/AAC.5.2.119.
本文引用的文献
1
Absorption and excretion of a new antibiotic (BRL 1241).一种新型抗生素（BRL 1241）的吸收与排泄
Br Med J. 1960 Sep 3;2(5200):700-3. doi: 10.1136/bmj.2.5200.700.
2
Prophylaxis and therapy for Pseudomonas aeruginosa infection with carbenicillin and with gentamicin.用羧苄青霉素和庆大霉素对铜绿假单胞菌感染进行预防和治疗。
Br Med J. 1967 Jul 8;3(5557):79-82. doi: 10.1136/bmj.3.5557.79.
3
Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea.羧苄青霉素的临床及实验室研究。一种对绿脓杆菌有效的新型青霉素。
Lancet. 1967 Jun 17;1(7503):1289-93. doi: 10.1016/s0140-6736(67)91590-5.
Zotero 插件